Late-Breaking News

“That’s What She Said…” 25 Great Quotes from Women Leaders

Have you ever stopped to celebrate the social, economic, cultural, and political achievement of women all over the world? At ZoomInfo, compiled some powerful messages from 25 influential women in business, from entrepreneurs to CEOs, to engineers, to world-renowned thought leaders–some of the most admired women executives and experts in their industries. Womensbiz.us is all …

“That’s What She Said…” 25 Great Quotes from Women Leaders READ MORE

CDC Dr. Rochelle Walensky Interview With Katie Couric

In a note on her official website titled “I Stand With Neil Young!,” Mitchell wrote: “I’ve decided to remove all my music from Spotify. Irresponsible people are spreading lies that are costing people their lives. I stand in solidarity with Neil Young and the global scientific and medical communities on this issue.”

Pharma Powerhouse – Organon – on Women’s Healthcare

Organon “envisions a better and healthier every day for every woman” by focusing on medical issues and targeted solutions impacting women.  Today it’s a global healthcare company formed through a spinoff from Merck, and builds upon their strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, …

Pharma Powerhouse – Organon – on Women’s Healthcare READ MORE

BrainScope and Aon Secure IP-based Funding Deal

Brain-assessment device innovator BrainScope, and Aon plc (NYSE: AON), a leading global professional services firm, today announced the completion of an intellectual property-based funding arrangement. The funding arrangement provides BrainScope with up to $35 million in capital to fund the full expansion of its commercial activities as well as to develop new clinical applications on its platform. “More than four million …

BrainScope and Aon Secure IP-based Funding Deal READ MORE

FDA Approves Verzenio® (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain High Risk Early Breast Cancer

Eli Lilly announced last month that the U.S. Food and Drug Administration (FDA) had approved its Verzenio (abemaciclib) for a specific type of early breast cancer that is at high risk of recurrence after surgery. The drug is limited to patients who test at least 20% for a Ki-67 score on an FDA-approved test. Ki-67 is a marker of cellular …

FDA Approves Verzenio® (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain High Risk Early Breast Cancer READ MORE

Trial For World’s First Potential Breast Cancer Vaccine Begins

Researchers at the Cleveland Clinic are set to launch the Phase I trial for what could be the first-ever vaccine to prevent triple-negative breast cancer. The decision to move forward with the trial comes on the heels of the U.S. Food and Drug Administration‘s approval of its Investigational New Drug (IND) application, allowing Cleveland Clinic and its partner, Anixa Biosciences, …

Trial For World’s First Potential Breast Cancer Vaccine Begins READ MORE

Shopping Cart
Scroll to Top